Rob Hallifax
PhD MRCP BMBCh MSci
Academic Clinical Lecturer in Respiratory Medicine
Dr Hallifax is an NIHR Academic Clinical Lecturer the University of Oxford. He studied an MSc in Natural Sciences in Cambridge before training in medicine at the University of Oxford.
He won an MRC Clinical Training Fellowship for his DPhil: "Understanding Pneumothorax: epidemiology, physiology and outcomes", and published the results in JAMA and Thorax.
Dr Hallifax is the trial coordinator for RAMPP (Randomised Ambulatory Management of Primary Pneumothorax) - a multi-centre trial of 24 sites around the UK – which has now completed recruitment. He is trained in thoracoscopy, advanced pleural ultrasound and clinical trials methodology
Recent publications
-
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.
Journal article
Kanellakis NI. et al, (2020), Thorax
-
Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.
Journal article
Hallifax RJ. et al, (2020), Lancet (London, England), 396, 39 - 49
-
Intercostal vessel screening prior to pleural interventions by the respiratory physician: a prospective study of real world practice.
Journal article
Bedawi EO. et al, (2020), The European respiratory journal, 55
-
Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set.
Journal article
Mercer RM. et al, (2019), Respirology (Carlton, Vic.)
-
Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial
Journal article
Hallifax R. et al, (2019), BMJ Open Respiratory Research, 6, e000403 - e000403